Correlation Between Xinjiang Baodi and Bloomage Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xinjiang Baodi and Bloomage Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xinjiang Baodi and Bloomage Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xinjiang Baodi Mining and Bloomage Biotechnology Corp, you can compare the effects of market volatilities on Xinjiang Baodi and Bloomage Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xinjiang Baodi with a short position of Bloomage Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xinjiang Baodi and Bloomage Biotechnology.

Diversification Opportunities for Xinjiang Baodi and Bloomage Biotechnology

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Xinjiang and Bloomage is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Xinjiang Baodi Mining and Bloomage Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bloomage Biotechnology and Xinjiang Baodi is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xinjiang Baodi Mining are associated (or correlated) with Bloomage Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bloomage Biotechnology has no effect on the direction of Xinjiang Baodi i.e., Xinjiang Baodi and Bloomage Biotechnology go up and down completely randomly.

Pair Corralation between Xinjiang Baodi and Bloomage Biotechnology

Assuming the 90 days trading horizon Xinjiang Baodi Mining is expected to generate 0.64 times more return on investment than Bloomage Biotechnology. However, Xinjiang Baodi Mining is 1.55 times less risky than Bloomage Biotechnology. It trades about 0.06 of its potential returns per unit of risk. Bloomage Biotechnology Corp is currently generating about -0.02 per unit of risk. If you would invest  579.00  in Xinjiang Baodi Mining on October 13, 2024 and sell it today you would earn a total of  92.00  from holding Xinjiang Baodi Mining or generate 15.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Xinjiang Baodi Mining  vs.  Bloomage Biotechnology Corp

 Performance 
       Timeline  
Xinjiang Baodi Mining 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Xinjiang Baodi Mining are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Xinjiang Baodi may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Bloomage Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bloomage Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Xinjiang Baodi and Bloomage Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xinjiang Baodi and Bloomage Biotechnology

The main advantage of trading using opposite Xinjiang Baodi and Bloomage Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xinjiang Baodi position performs unexpectedly, Bloomage Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bloomage Biotechnology will offset losses from the drop in Bloomage Biotechnology's long position.
The idea behind Xinjiang Baodi Mining and Bloomage Biotechnology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance